PAVmed Inc Total Liabilities
PAVmed Inc total liabilities. Based on the latest financial reports, PAVmed Inc (PAVM) has total liabilities worth $12.28 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check PAVmed Inc liquidity resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of PAVmed Inc (2014–2024)
Total liabilities of PAVmed Inc from 2014 to 2024. This chart illustrates how PAVmed Inc's total liabilities have evolved over time, based on quarterly financial data. Explore PAVmed Inc (PAVM) long-term investment share to see how much of total assets are deployed in long-term investments.
PAVmed Inc Competitors by Total Liabilities
The table below lists competitors of PAVmed Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Camellia Plc
LSE:CAM
|
UK | GBX128.80 Million |
|
abrdn European Logistics Income PLC
LSE:ASLI_old
|
UK | GBX255.35 Million |
|
Cynata Therapeutics Ltd
AU:CYP
|
Australia | AU$1.22 Million |
|
Netmedia Group S.A.
PA:ALNMG
|
France | €19.40 Million |
|
Cobra Venture Corp
V:CBV
|
Canada | CA$155.40K |
|
Dragon Mountain Gold Ltd
AU:DMG
|
Australia | AU$878.63K |
|
Star Pacific Tbk
JK:LPLI
|
Indonesia | Rp5.88 Billion |
Liability Composition Analysis (2014–2024)
This chart breaks down PAVmed Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see balance sheet size of PAVmed Inc.
Liquidity & Leverage Metrics
PAVmed Inc Total Liabilities Ratios Explained
PAVmed Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.40 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.34 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.32 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how PAVmed Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for PAVmed Inc (2014–2024)
The table below shows the annual total liabilities of PAVmed Inc from 2014 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $37.69 Million | -34.03% |
| 2023-12-31 | $57.14 Million | +32.73% |
| 2022-12-31 | $43.05 Million | +469.54% |
| 2021-12-31 | $7.56 Million | -62.68% |
| 2020-12-31 | $20.25 Million | +70.48% |
| 2019-12-31 | $11.88 Million | +8.26% |
| 2018-12-31 | $10.97 Million | +144.49% |
| 2017-12-31 | $4.49 Million | +277.31% |
| 2016-12-31 | $1.19 Million | +105.02% |
| 2015-12-31 | $580.17K | +1127.90% |
| 2014-12-31 | $47.25K | -- |
About PAVmed Inc
PAVmed Inc. engages in acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing… Read more